This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its structure, featuring both amino and fluoropyridine groups, makes it valuable for the development of drugs targeting neurological and psychiatric disorders. Specifically, it is employed in the production of compounds that modulate neurotransmitter systems, such as GABA receptors, which are critical in managing conditions like anxiety, epilepsy, and insomnia. Additionally, its fluorinated pyridine moiety enhances the bioavailability and metabolic stability of the resulting drugs, making it a preferred choice in medicinal chemistry. Researchers also explore its potential in creating novel therapeutic agents for treating chronic pain and inflammation due to its unique chemical properties.